Trity Environ Solutions is a trusted pharmaceutical effluent treatment plant manufacturer in India, engineering systems built to handle API residues, solvents, and high COD loads that a generic ETP design cannot manage safely. Our plants are designed as a layered treatment train around your specific process, with pan India installation support.
Pharmaceutical effluent carries API residues, solvents, and COD loads that a generic industrial effluent treatment plant design cannot handle safely, often arriving several times stronger than typical industrial wastewater. Trity Environ Solutions builds pharma ETP systems as a layered treatment train, combining solvent stripping, advanced physico-chemical treatment, and biological COD reduction so each stage prepares the effluent for the next, rather than aerating pollution the system can never remove.
Manufacturing APIs or bulk drugs and need a compliant ETP? Request a free technical assessment and our engineering team will design a treatment train around your actual effluent profile.
Get the sequencing wrong on a pharma ETP and you build a plant that aerates pollution it can never remove. Trity Environ Solutions designs each stage to prepare the effluent for the next, pooling and balancing batch flows, stripping volatile solvents before biology, and breaking down refractory API residues through advanced oxidation, so the biological stage only handles what it is actually capable of treating.
Pharmaceutical manufacturing faces some of the strictest environmental scrutiny in India, with antibiotic residues now a flagged regulatory concern alongside standard CPCB and SPCB norms. Trity Environ Solutions backs every pharmaceutical ETP with operator training, compliance documentation support, and an Annual Maintenance Contract, so your plant stays audit ready. Talk to our team about AMC coverage for your facility.
Removes volatile organic solvents from pharmaceutical effluent before biological treatment, preventing them from disrupting the downstream microbial treatment process.
Ozone, UV, or Fenton reagent based systems break down non-biodegradable API residues and refractory organics into forms biology can treat.
High rate biological stage, often membrane bioreactor based, digests biodegradable COD and BOD load under closely controlled aeration conditions.
RO and evaporator based configuration for API units under Zero Liquid Discharge mandate, recovering water while crystallising the concentrated reject.
Pharmaceutical effluent carries high COD, API residues, and solvents that a generic ETP design cannot break down safely, requiring a specifically engineered, multi-stage treatment train.
API manufacturing effluent can range from 3,000 to over 10,000 mg/L COD, compared to around 450 to 550 mg/L for domestic sewage, making pretreatment essential before biological treatment.
CPCB mandates Zero Liquid Discharge for many API and bulk drug manufacturing units, though specific requirements depend on unit size and state regulations.
API residues are typically broken down using advanced oxidation processes such as ozone, UV, or Fenton's reagent, converting them into forms that biological treatment can then process.
Untreated antibiotic residues in effluent can contribute to antimicrobial resistance in the environment, making their removal an increasing regulatory and public health priority.
With reverse osmosis and appropriate polishing, treated pharmaceutical effluent can often be reused on site, reducing freshwater dependency and supporting ZLD compliance. ---
Our engineering team can help design the right system for your capacity, industry, and compliance requirements.